ABIVAX Société Anonyme
ABVXNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $7.01B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $69.81$148.83
- Volume (live)
- -
- Avg. volume (3M)
- 1.36M
ABIVAX Société Anonyme (ABVX) Stock Price & Financial Analysis
ABIVAX Société Anonyme Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $87.03 - $89.60 |
|---|---|
| 52-Week High | $148.83 |
| 52-Week Low | $69.81 |
| Open | $89.60 |
| Volume (last close) | 431.79K |
| Average Volume (3M) | 1.36M |
| Revenue (TTM) | 2.22M |
|---|---|
| Net Income (TTM) | -449.10M |
| Free Cash Flow (TTM) | -220.81M |
| EPS (TTM) | −$5.97 |
| Profit Margin | -20232.93% |
| Operating Margin | -14760.46% |
| Return on Equity (ROE) | -109.54% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 7.01B |
|---|---|
| Shares Outstanding | 79.65M |
| Price to Sales (P/S) | 3158.09 |
| Price to Book (P/B) | 17.10 |
| EV/EBITDA | -15.97 |
| 50-Day MA | $105.34 |
|---|---|
| 200-Day MA | $115.35 |
| 1-Year Change | −0.27% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
ABIVAX Société Anonyme at a Glance
As of the Oct 23, 2026 close, ABIVAX Société Anonyme (ABVX) has a market capitalization of $7.01B. The stock trades at 3158.1× sales. Over the trailing twelve months it lost $449.10M on revenue of $2.22M and burned $220.81M of free cash flow. Revenue fell 41.3% year over year.
As of its latest reported balance sheet, it holds $434.29M in cash and securities against $1.36M of debt, a net cash position of $432.94M.
ABIVAX Société Anonyme does not currently pay a dividend.
The share price is down 0.3% over the past year. At $88.01 (the Oct 23, 2026 close) it sits within its 52-week range of $69.81 to $148.83, below its 200-day moving average of $115.35.
Based on 9 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $156.43, 77.7% above the Oct 23, 2026 close.
Frequently Asked Questions About ABIVAX Société Anonyme
What is the current stock price for ABVX?
As of the Oct 23, 2026 close, ABVX stock trades at $88.01. The 52-week range is $69.81–$148.83, with a day range of $87.03–$89.60.
What is the P/E ratio for ABVX?
The P/E ratio (Price-to-Earnings) for ABVX is shown in the Key Statistics section. This valuation metric helps compare ABIVAX Société Anonyme to industry peers.
Does ABVX pay dividends?
ABIVAX Société Anonyme does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ABVX?
Based on ratings from 9 professional analysts over the last 90 days, the consensus for ABVX is Buy. The average 12-month price target is $156.43, a 77.7% upside from the Oct 23, 2026 close of $88.01.
What is the market cap of ABVX?
As of the Oct 23, 2026 close, ABIVAX Société Anonyme's market capitalization is $7.01B, classifying it as a mid-cap company. ABIVAX Société Anonyme operates in the Healthcare sector within the Biotechnology industry.